A trial HIV vaccine triggered elusive and essential antibodies in humans
An HIV vaccine candidate triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a 2019 clinical trial.
https://www.sciencedaily.com/r....eleases/2024/05/2405
Discover the world at Altruu, The Discovery Engine